Welcome to LookChem.com Sign In|Join Free

CAS

  • or

477603-35-3

2-ETHYL-BENZOOXAZOLE-4-YLAMINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

477603-35-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 477603-35-3 Structure

  • Basic information

    1. Product Name: 2-ETHYL-BENZOOXAZOLE-4-YLAMINE
    2. Synonyms: 2-ETHYL-BENZOOXAZOLE-4-YLAMINE
    3. CAS NO:477603-35-3
    4. Molecular Formula: C9H10N2O
    5. Molecular Weight: 162.191
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 477603-35-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-ETHYL-BENZOOXAZOLE-4-YLAMINE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-ETHYL-BENZOOXAZOLE-4-YLAMINE(477603-35-3)
    11. EPA Substance Registry System: 2-ETHYL-BENZOOXAZOLE-4-YLAMINE(477603-35-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 477603-35-3(Hazardous Substances Data)

477603-35-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 477603-35-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,7,6,0 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 477603-35:
(8*4)+(7*7)+(6*7)+(5*6)+(4*0)+(3*3)+(2*3)+(1*5)=173
173 % 10 = 3
So 477603-35-3 is a valid CAS Registry Number.

477603-35-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Ethyl-1,3-benzoxazol-4-amine

1.2 Other means of identification

Product number -
Other names 2-ethylbenzoxazole-4-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:477603-35-3 SDS

477603-35-3Downstream Products

477603-35-3Relevant articles and documents

CONDENSED HETEROCYCLIC COMPOUND

-

Paragraph 0270; 0273; 0274, (2017/11/08)

A compound represented by the general formula (I) [R1 represents a C1-6 alkyl group, a halogen atom, or the like; A represents a phenylene group, or the like; X represents —CH(R3)—, —O—, —NH—, or the like; Y represents —O—, —NH—, —N═, or —S—; . . . represents a single bond or double bond; n represents 1 to 3; R2 represents a C1-6 alkyl group, a C1-6 alkoxy group, or the like; and R3 represents hydrogen atom, a C1-6 alkyl group, or the like], or a salt thereof which has a blood LDL cholesterol-reducing action, and is useful as an active ingredient of medicaments.

Synthesis and antifungal activity of benzo[d]oxazole-4,7-diones

Ryu, Chung-Kyu,Lee, Ra-Young,Kim, Na Young,Kim, Yang Hui,Song, Ae Li

scheme or table, p. 5924 - 5926 (2010/07/05)

Benzo[d]oxazole-4,7-diones were synthesized and tested for in vitro antifungal activity against fungi. Among them tested, many compounds showed good antifungal activity. The results suggest that benzo[d]oxazole-4,7-diones would be potent antifungal agents.

Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C

Lavergne, Olivier,Fernandes, Anne-Cecile,Brehu, Laetitia,Sidhu, Alban,Brezak, Marie-Christine,Prevost, Gregoire,Ducommun, Bernard,Contour-Galcera, Marie-Odile

, p. 171 - 175 (2007/10/03)

A focused set of heterocyclic quinones based on the benzothiazole, benzoxazole, benzimidazole, indazole and isoindole was prepared and screened with respect to the inhibition of the phosphatase activity of CDC25C. Benzoxazole- and benzothiazole-diones wer

Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors

-

Page/Page column 24, (2008/06/13)

The invention concerns the use as cdc25 phosphatase inhibitors, in particular cdc25-C phosphatase, and CD45 phosphatase, of compounds of general formula (I), wherein: W represents O or S. In accordance with the invention, the compounds of general formula

Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent

-

Page/Page column 24, (2008/06/13)

A subject of the invention is a product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent for a therapeutic use which is simultaneous, separate or spread over time in the treatment of cancer. Acco

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 477603-35-3